Submitted by Anonymous (not verified) on 9 October 2025 - 14:50
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 12, Status: Authorised